in a population of neurons in the arcuate nucleus (ARC) of the hypothalamus and stimulates food intake for up to 7 days if injected intracerebroventricularly. The prolonged food intake stimulation does not seem to depend on continued competition at the melanocortin-4 receptor (MC4R), because the relatively specific MC4R agonist MTII regains its ability to suppress food intake 24 h after AgRP injection. Intracerebroventricular AgRP also stimulates c-Fos expression 24 h after injection in several brain areas, so the neurons exhibiting delayed Fos expression might be particularly important in feeding behavior. Thus we aimed to identify the neurochemical phenotype of some of these neurons in select hypothalamic areas, using double-label immunohistochemistry. AgRP-injected rats ingested significantly more chow (10.2 Ϯ 0.6 g) vs. saline controls (3.4 Ϯ 0.7 g) in the first 9 h (light phase) after injection. In the lateral hypothalamus (particularly the perifornical area) 23 h after injection, AgRP induced significantly more Fos vs. saline in orexin-A (OXA) neurons (25.6 Ϯ 4.9 vs. 4.8 Ϯ 3.1%), but not in melaninconcentrating hormone (MCH) or cocaine-and amphetamineregulated transcript (CART) neurons. In the ARC, AgRP induced significantly more Fos in CART (40.6 Ϯ 5.9 vs. 13.4 Ϯ 1.8%) but not NPY neurons. In the paraventricular nucleus, there was no significant difference in Fos expression induced by AgRP vs. saline in oxytocin and CART neurons. We conclude that the long-lasting hyperphagia induced by AgRP is correlated with and possibly partially mediated by hyperactive OXA neurons in the lateral hypothalamus and CART neurons in the ARC, but not by NPY and MCH neurons. The substantial increase in light-phase food intake by AgRP supports a role for the arousing effects of OXA. Activation of CART neurons in the ARC (which likely coexpress proopiomelanocortin) could indicate attempts to activate counterregulatory decreases in food intake. food intake; cocaine-and amphetamine-regulated transcript; neuropeptide Y; oxytocin; lateral hypothalamus; paraventricular nucleus; arcuate nucleus AGOUTI-RELATED PROTEIN (AgRP) is coexpressed with neuropeptide Y (NPY) in a population of neurons in the medial aspects of the arcuate nucleus (ARC) of the hypothalamus (17, 30). AgRP/NPY neurons project locally, within the ARC (3, 19), to the paraventricular nucleus (PVN) (25, 36), dorsomedial nucleus (50), perifornical hypothalamus (13, 23), and several other brain areas (3).AgRP competes with ␣-melanocyte-stimulating hormone (␣-MSH) for the melanocortin-4 receptor (MC4R) and thus acts as an endogenous antagonist of MC4R (38,49,69). Stimulation of MC4R in the hypothalamus with the natural ligand ␣-MSH (63) or with pharmacological agonists such as MTII (46, 61) suppresses food intake. In contrast, intracerebroventricular injection of AgRP induces robust food intake (54) that lasts for several days (29). In addition, overexpression of AgRP (27) and chronic facilitation of AgRP receptor binding via overexpression of syndecan (51) lead to obesit...